FARE Augmentation of Proximal Femoral Fractures With CaS/HA and Systemic ZA
Status:
Recruiting
Trial end date:
2025-06-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to investigate the new bone formation around a metal
device in the femoral head in patients with osteoporotic hip fractures undergoing surgical
treatment with nails. These surgeries have a high risk of fixation failure in patients with
osteoporosis due to low bone quality. The main question we aim to answer are whether
promoting new bone formation around the implant is possible with a bone graft substitute
(CERAMENT™ Bone Void Filler) and systemic osteoporosis drug (zoledronic acid) combination,
which can strengthen the surgical fixation of the fracture. Participants will consist of
patients suffering hip fracture and already scheduled for surgical treatment with a nail. One
group will undergo conventional surgery. While the other group will also undergo the same
surgery, they will receive CERAMENT™ Bone Void Filler around the implant as a short, extra
step during surgery. This will allow the researchers to see whether new bone is formed during
a 6-month follow-up.